Drugs & Diseases

Recent Drug Updates

  • rivaroxaban (Xarelto) New indication approved for prevention of CV events in CAD, PAD
  • elapegademase (Revcovi) New enzyme replacement therapy approved for treatment of severe combined immune deficiency
  • inotersen (Tegsedi) FDA approves antisense oligonucleotide for polyneuropathy of hereditary transthyretin amyloidosis

Slideshow Collections